Your search for oral corticosteroids returned 40 results

Zolgensma is an adeno-associated virus vector-based gene therapy.

The approval was based on data from the randomized, double-blind, placebo-controlled phase 3 VOYAGE trial.

Research presented at CHEST 2021 assessed an alternative approach to predicting COPD exacerbations during the COVID-19 pandemic.

A post-hoc analysis of the VENTURE trial evaluated whether baseline oral corticosteroid dosage affected the efficacy of dupilumab in improving severe asthma outcomes.

NAVIGATOR trial results presented at CHEST 2021 show the effect of tezepelumab on peak expiratory flow rates in severe asthma.

Study authors evaluated the impact on compliance and SNOT-20 scores in patients with allergic rhinitis using a novel sinus nasal rinse device.

In their presentation, Ahmad R. Sedaghat, MD, PhD and Stacey T. Gray, MD, FACS discuss both patient and physician perspectives for successful control of CRS.

Study authors conducted a prospective randomized trial to determine if there is a role for oral steroids in patients who have CRSsNP.

The most common presenting complaints included shortness of breath, rhinorrhea, and hoarseness.

Rilzabrutinib is an oral Bruton tyrosine kinase inhibitor currently in development for a number of immune-mediated diseases.